Financial results - RTS START PHARM SRL

Financial Summary - Rts Start Pharm Srl
Unique identification code: 29422593
Registration number: J2011000766524
Nace: 4773
Sales - Ron
319.554
Net Profit - Ron
14.980
Employees
5
Open Account
Company Rts Start Pharm Srl with Fiscal Code 29422593 recorded a turnover of 2024 of 319.554, with a net profit of 14.980 and having an average number of employees of 5. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Rts Start Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 93.201 84.556 49.580 37.908 55.769 122.088 85.819 79.103 336.386 319.554
Total Income - EUR 93.235 84.558 49.743 37.908 55.885 122.262 85.827 92.225 336.412 319.569
Total Expenses - EUR 96.221 86.343 54.381 47.408 36.822 98.532 98.846 109.673 303.040 301.388
Gross Profit/Loss - EUR -2.986 -1.785 -4.638 -9.499 19.063 23.730 -13.018 -17.448 33.372 18.181
Net Profit/Loss - EUR -4.102 -2.631 -5.135 -9.879 18.504 22.336 -14.131 -18.457 29.826 14.980
Employees 3 4 3 4 3 4 5 5 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -4.5%, from 336.386 euro in the year 2023, to 319.554 euro in 2024. The Net Profit decreased by -14.679 euro, from 29.826 euro in 2023, to 14.980 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Rts Start Pharm Srl

Rating financiar

Financial Rating -
RTS START PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Rts Start Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Rts Start Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Rts Start Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Rts Start Pharm Srl - CUI 29422593

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 197 100 67 565 336 24.991 19.169 1.387 1.084 1.416
Current Assets 24.987 23.446 20.530 18.814 44.557 66.173 33.827 85.564 148.736 86.554
Inventories 5.362 10.429 7.235 5.790 14.846 4.345 7.607 54.076 42.204 23.973
Receivables 14.993 9.044 12.796 12.362 29.190 53.365 23.216 22.447 94.746 56.508
Cash 4.632 3.974 499 662 521 8.462 3.003 9.041 11.785 6.073
Shareholders Funds 7.497 4.790 -427 -10.298 8.406 30.582 15.773 -2.635 27.199 16.636
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 17.686 18.756 21.023 29.677 36.487 60.582 37.222 89.586 122.620 71.334
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 86.554 euro in 2024 which includes Inventories of 23.973 euro, Receivables of 56.508 euro and cash availability of 6.073 euro.
The company's Equity was valued at 16.636 euro, while total Liabilities amounted to 71.334 euro. Equity decreased by -10.411 euro, from 27.199 euro in 2023, to 16.636 in 2024.

Risk Reports Prices

Reviews - Rts Start Pharm Srl

Comments - Rts Start Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.